The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice.
about
The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activationPhase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell DiseaseSafety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.Nrf2 at the Heart of Oxidative Stress and Cardiac Protection.RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene.
P2860
The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@en
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@nl
type
label
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@en
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@nl
prefLabel
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@en
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@nl
P2093
P2860
P356
P1433
P1476
The triterpenoid RTA 408 is a ...... te radiation syndrome in mice.
@en
P2093
Chandan Guha
Devorah C Goldman
Elizabeth Lash
Ulrich Rodeck
Vitali Alexeev
William H Fleming
P2860
P304
P356
10.1667/RR13900.1
P577
2015-03-04T00:00:00Z